@article{AES4639,
author = {Adam Wylęgała and Edward Wylęgała},
title = {Anti-vascular endothelial growth factor and macular atrophy: an unanswered question},
journal = {Annals of Eye Science},
volume = {3},
number = {12},
year = {2018},
keywords = {},
abstract = {Does anti-vascular endothelial growth factor (VEGF) therapy lead to geographic atrophy? If so, does the number of injections or the duration of anti-VEGF therapy correlate with the risk of developing geographic atrophy? With intravitreal injections becoming the most common ophthalmic invasive procedure and an increasingly aging population, these questions really matter.},
issn = {2520-4122}, url = {https://aes.amegroups.org/article/view/4639}
}